Acasti Pharma, Inc. - (ACST) Social Stream



Acasti Pharma, Inc. - (ACST): $2.62

0.01 (-0.38%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add ACST to Watchlist
Sign Up

ACASTI PHARMA INC (ACST) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ACST.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-22 1 $6 $6 $6 $2.72 120.59%
2022-06-22 1 $5 $5 $5 $2.72 83.82%
2022-11-16 1 $2 $2 $2 $2.72 -26.47%
2022-12-15 2 $2.4 $2 $2.2 $2.72 -19.12%
2023-02-15 2 $14.997 $14.397 $14.697 $2.72 440.33%
2023-05-09 3 $2.5 $2 $2.3 $2.72 -15.44%
2023-10-17 2 $12 $2.501 $7.25 $2.72 166.54%

The Trend in the Analyst Price Target


ACST's average price target has moved up $11.49 over the prior 26 months.

ACST reports an average of 606.77% for its upside potential over the past 35 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-15 2 14.997 14.397 14.697 0.640 2196.41%
2023-07-12 2 14.997 12.000 13.498 2.562 426.85%
2023-10-17 2 12.000 2.501 7.250 2.610 177.78%
2023-10-17 1 12.000 2.501 7.250 2.610 177.78%
2023-10-17 1 14.997 12.000 13.498 2.610 417.16%

ACST Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


Over the past 36 months, ACST's average broker recommendation rating improved by 1.5.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • ACASTI PHARMA INC's number of analysts covering the stock is greater than 18.7% of all US stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ACASTI PHARMA INC's variance in analysts' estimates is lower than -16.39% of them.
  • In terms of how ACASTI PHARMA INC fares relative to Healthcare stocks, note that its average analyst price target is higher than 103.51% of that group.
  • To contextualize these metrics, consider that out of Healthcare stocks, ACASTI PHARMA INC's upside potential (average analyst target price relative to current price) is greater than 418.86% of them.

In the Pharmaceutical Products industry, CANF, BLRX, and GLMD are the three stocks most similar to ACASTI PHARMA INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding ACST using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!